Omada Health (NASDAQ:OMDA) Issues Quarterly Earnings Results, Beats Estimates By $0.21 EPS

Omada Health (NASDAQ:OMDA) posted its quarterly earnings data on Thursday. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.21, Zacks reports. Omada Health updated its FY 2025 guidance to EPS.

Omada Health Stock Performance

Omada Health stock traded down $1.43 during mid-day trading on Thursday, hitting $21.87. 1,231,939 shares of the stock were exchanged, compared to its average volume of 395,923. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40. The firm’s fifty day moving average price is $23.77.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on OMDA shares. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a research report on Wednesday, October 8th. Canaccord Genuity Group lifted their price target on shares of Omada Health from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, August 8th. Robert W. Baird initiated coverage on shares of Omada Health in a research report on Friday, September 5th. They issued a “neutral” rating and a $24.00 price objective on the stock. Barclays upped their price target on shares of Omada Health from $24.00 to $28.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Finally, Evercore ISI set a $27.00 price objective on shares of Omada Health in a report on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $25.50.

Institutional Trading of Omada Health

Several hedge funds have recently bought and sold shares of OMDA. Perceptive Advisors LLC purchased a new position in Omada Health during the 2nd quarter worth $44,402,000. Bank of America Corp DE bought a new stake in shares of Omada Health during the second quarter valued at about $1,124,000. Hudson Bay Capital Management LP bought a new position in shares of Omada Health in the second quarter worth approximately $1,107,000. Gilder Gagnon Howe & Co. LLC bought a new position in shares of Omada Health in the second quarter worth approximately $1,057,000. Finally, Soros Fund Management LLC bought a new position in Omada Health during the second quarter valued at approximately $640,000.

Omada Health Company Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.